Aptahem AB
556970-5782ActiveBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Biotechnology Companyaptahem.com
Oversikt
- 1–4
- Ansatte
- ≤1t SEK
- Omsetning
- 2014
- Grunnlagt
Nøkkelbeslutningstakere
Mikael Lindstam
CEO
Beskrivelse
Aptahem is a specialized biotechnology company focused on developing novel RNA-based pharmaceuticals. Their primary mission is to create disruptive treatments for acute, life-threatening inflammatory diseases, such as sepsis. The company's lead drug candidate, Apta-1, is currently progressing throug...
Tagger
B2BPharmaceuticals
Nøkkelord
AptamersBiotechnology